Bovyuan Corporation: Iodide products have not yet been sold in the field of solid-state batteries.
The announcement of abnormal stock trading by Boyuan Group stated that the closing price of the company's stock has deviated by more than 30% for three consecutive trading days on September 5, 8, and 9, 2025, indicating abnormal fluctuations in stock trading. After verification, the company's operations are normal, and there have been no significant changes recently. No significant undisclosed information that may have a significant impact on the company's stock trading price has been found in public media reports. The controlling shareholder and actual controller of the company have no major undisclosed issues or major issues in the planning stage that should be disclosed by the company.
At the same time, the company has noticed the recent high market attention to solid-state battery-related concepts. However, the company's iodide products are currently mainly used in the fields of medicine, chemical industry, optoelectronic materials, feed, and food, and have not yet achieved sales in the area of solid-state batteries. The company will focus on its main business, actively explore new applications in new industry sectors, conduct feasibility studies, and cautiously explore and try new business areas.
Latest